Modulation of the tight junctions of the Caco-2 cell monolayers by H2-antagonists

被引:31
作者
Gan, LSL
Yanni, S
Thakker, DR
机构
[1] Glaxo Inc, Dept Drug Metab, Res Triangle Pk, NC 27709 USA
[2] Univ N Carolina, Sch Pharm, Div Pharmaceut, Chapel Hill, NC 27599 USA
关键词
H-2-antagonists; ranitidine; tight junctions; Caco-2; paracellular transport; in vitro model;
D O I
10.1023/A:1011944602662
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The tight junctions in the intestinal epithelium represent highly specialized intercellular junctions. Ranitidine, an H-2-antagonist, causes a tightening of the tight junctions. Hence, we have investigated the effect of ranitidine and other H-2-antagonists on the function of the intestinal tight junctions. Methods. Effect of the H-2-antagonists on the tight junctions has been investigated using the transepithelial electrical resistance (TEER) and the transport of mannitol across the Caco-2 cell monolayers. Results. Four different H-2-antagonists caused an increase in the TEER across the Caco-2 cell monolayers, accompanied by a decrease in the permeability for mannitol. The effect was concentration-dependent and saturable. Ranitidine and famotidine, caused a decrease in their own transport rate across the Caco-2 cells. Ranitidine competitively inhibited the increase in TEER caused by famotidine, whereas compounds which represent molecular fragments of ranitidine had no effect The relative potency of the four H-2-antagonists in causing an increase in the TEER correlated inversely with the oral bioavailability of these compounds in humans. Conclusions. We hypothesize that the H-2-antagonists exert their effect on the tight junctions of Caco-2 cells by modulation of interactions among proteins associated with the tight junctional complex.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 17 条
[1]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[2]  
CEREIJIDO M, 1993, J CELL SCI, P127
[3]   CLINICAL PHARMACOKINETICS OF FAMOTIDINE [J].
ECHIZEN, H ;
ISHIZAKI, T .
CLINICAL PHARMACOKINETICS, 1991, 21 (03) :178-194
[4]   MECHANISM OF INTESTINAL-ABSORPTION OF RANITIDINE AND ONDANSETRON - TRANSPORT ACROSS CACO-2 CELL MONOLAYERS [J].
GAN, LS ;
HSYU, PH ;
PRITCHARD, JF ;
THAKKER, D .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1722-1725
[5]  
HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736
[6]   CACO-2 CELL MONOLAYERS AS A MODEL FOR DRUG TRANSPORT ACROSS THE INTESTINAL-MUCOSA [J].
HILGERS, AR ;
CONRADI, RA ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1990, 7 (09) :902-910
[7]   ABSORPTION STUDIES OF THE H-2-BLOCKER NIZATIDINE [J].
KNADLER, MP ;
BERGSTROM, RF ;
CALLAGHAN, JT ;
OBERMEYER, BD ;
RUBIN, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) :514-520
[8]   STRUCTURE AND FUNCTION OF DESMOSOMAL TRANSMEMBRANE CORE AND PLAQUE MOLECULES [J].
KOWALCZYK, AP ;
STAPPENBECK, TS ;
PARRY, DAD ;
PALKA, HL ;
VIRATA, MLA ;
BORNSLAEGER, EA ;
NILLES, LA ;
GREEN, KJ .
BIOPHYSICAL CHEMISTRY, 1994, 50 (1-2) :97-112
[9]   PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF HISTAMINE H-2-RECEPTOR ANTAGONISTS - RELATIONSHIP BETWEEN INTRINSIC POTENCY AND EFFECTIVE PLASMA-CONCENTRATIONS [J].
LIN, JH .
CLINICAL PHARMACOKINETICS, 1991, 20 (03) :218-236
[10]   TIGHT JUNCTION DYNAMICS - IS PARACELLULAR TRANSPORT REGULATED [J].
MADARA, JL .
CELL, 1988, 53 (04) :497-498